0001865257-26-000005.txt : 20261021 0001865257-26-000005.hdr.sgml : 20261021 20261021100446 ACCESSION NUMBER: 0001865257-26-000005 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261021 DATE AS OF CHANGE: 20261021 EFFECTIVENESS DATE: 20261021 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Allyx Therapeutics, Inc. CENTRAL INDEX KEY: 0001865257 ORGANIZATION NAME: EIN: 832648948 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-583522 FILM NUMBER: 261474432 BUSINESS ADDRESS: STREET 1: 470 JAMES STREET STREET 2: SUITE 007 CITY: NEW HAVEN STATE: CT ZIP: 06513 BUSINESS PHONE: 2038550400 MAIL ADDRESS: STREET 1: 470 JAMES STREET STREET 2: SUITE 007 CITY: NEW HAVEN STATE: CT ZIP: 06513 D/A 1 primary_doc.xml X0708 D/A LIVE 0001865257 Allyx Therapeutics, Inc. 555 Long Wharf Drive Floor 11 NEW HAVEN CT CONNECTICUT 06511 (908) 432-2845 DELAWARE None None Corporation true Stephen Bloch c/o Allyx, 555 Long Wharf Drive Floor 11 New Haven CT CONNECTICUT 06511 Executive Officer Director Stephen Strittmatter c/o Allyx, 555 Long Wharf Drive Floor 11 New Haven CT CONNECTICUT 06511 Director Paul Fonteyne c/o Allyx, 555 Long Wharf Drive Floor 11 New Haven CT CONNECTICUT 06511 Director Gregory P Ho c/o SMC, 650 Madison Avenue 20th Floor New York NY NEW YORK 10022 Director Robert A Bettigole c/o ESV, 33 Whitney Avenue New Haven CT CONNECTICUT 06510 Director Timothy Siegert c/o Allyx, 555 Long Wharf Drive Floor 11 New Haven CT CONNECTICUT 06511 Executive Officer Kevin L. Rakin 25 Norwalk Avenue Westport CT CONNECTICUT 06880 Director Biotechnology Decline to Disclose 06b true 0001865257-26-000004 2026-05-04 false true true true false 0 Supervision Partners LLC 300528 None None 641 Lexington Avenue FL 17 New York NY NEW YORK 10022 AL ALABAMA CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE FL FLORIDA GA GEORGIA HI HAWAII IL ILLINOIS IA IOWA KY KENTUCKY ME MAINE MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MO MISSOURI NV NEVADA NH NEW HAMPSHIRE NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OH OHIO OK OKLAHOMA PA PENNSYLVANIA RI RHODE ISLAND SC SOUTH CAROLINA TN TENNESSEE TX TEXAS UT UTAH VA VIRGINIA WA WASHINGTON WI WISCONSIN true 29999999 27927729 2072270 false 33 0 328671 0 No amount other than ordinary course employment compensation is being paid to officers and directors. false Allyx Therapeutics, Inc. Dr. Stephen Bloch Dr. Stephen Bloch Chief Executive Officer 2026-10-21